The upside case is not a reactor moonshot. BWXT already owns scarce, licensed nuclear throughput and trusted government positions, so it can compound through
backlog conversion, commercial component expansion, special-materials work and selective new nuclear programs. That mix can drive solid revenue growth while preserving a premium industrial multiple, but licensing and procurement keep the outcome in fast-compounder territory rather than hypergrowth.